|
n
|
83
|
71
|
NA
|
|
Male, n (%)
|
44/83 (53.0)
|
31/71 (43.7)
|
0.247
|
|
Age at diagnosis of MP pneumonia, years
|
6.1 ± 4.2
|
5.9 ± 3.4
|
0.757
|
|
Total duration of fever during the illness, days
|
5.2 ± 7.6
|
9.1 ± 4.6
|
< 0.001
|
|
Total hospitalization duration, days
|
9.0 ± 5.3
|
10.1 ± 5.3
|
0.200
|
|
Development of any extra-pulmonary symptoms, n (%)
|
10/83 (12.0)
|
26/71 (36.6)
|
< 0.001
|
|
Pleural effusion, yes, n (%)
|
9/83 (10.8)
|
16/71 (22.5)
|
0.050
|
|
Oxygen need, yes, n (%)
|
4/83 (4.8)
|
6/71 (8.5)
|
0.362
|
|
Respiratory virus co-infection, yes, n (%)
|
30/83 (36.1)
|
35/71 (49.3)
|
0.100
|
|
Positive results on pneumobacter PCR except MP, n (%)
|
13/32 (40.6)
|
14/41 (34.1)
|
0.569
|
|
Macrolide resistant MP, n (%)
|
58/80 (72.5)
|
59/66 (89.4)
|
0.011
|
|
Response to stepwise treatment for MP pneumonia, n (%)
|
0.657
|
|
Good response
|
34/83 (41.0)
|
24/71 (33.8)
| |
|
Poor response
|
49/83 (59.0)
|
47/71 (66.2)
| |
|
Severity of pneumonia based on chest radiography
|
0.089
|
|
Mild
|
12/83 (14.5)
|
6/71 (8.5)
| |
|
Moderate
|
57/83 (68.7)
|
43/71 (60.6)
| |
|
Severe
|
14/83 (16.9)
|
22/71 (31.0)
| |